NCT05696496

Brief Summary

If the video-polysomnographic (vPSG) recording in the laboratory remains the reference examination in Sleep Medicine Centers for the diagnosis of sleep pathologies, the high prevalence of sleep disorders in the general population and the growing demand for exploration and management may require the use of alternative techniques such as new sleep recording or analysis devices. In collaboration with the Creative Mechatronics Company (Issoire) and the Ennery Confection Company (Le Puy en Velay), we have developed a "portable" sleep detection prototype called Easy Sleep Monitoring (ESM) which consists of an "intelligent" duvet equipped with a series of sensors capable of detecting movements and, through this, estimating sleep duration and quantifying motor phenomena during sleep. Indeed, it is a duvet which has in its thickness a grid of 35 electronic cards, equipped with an actimetric sensor and a temperature sensor. The distribution of the sensors makes it possible to detect the motor activity of the sleeper on all the body regions by considerably increasing the sensitivity and specificity compared to actimetry at the wrist. The advantage of this duvet compared to other "wearable" devices is represented by its ease of use, being less restrictive, having a reduced implementation time and not requiring the user's collaboration. For example, it could be used for sleep monitoring in the elderly and/or in a situation of hypomobility in the context of Residential establishment for dependent elderly people or hospitals. At home, it could be a sleep monitoring tool, such as monitoring treatment for insomnia, medicinal or not, or to monitor motor activity during sleep, as in the monitoring of nocturnal akinesia in parkinsonian patients. The main objective of this study is to evaluate the concordance of sleep data obtained with the ESM duvet with those obtained by video-polysomnography (vPSG). Indeed, the vPSG is the gold standard examination in the study of sleep, the only one capable of exactly defining the different stages of sleep and precisely quantifying sleep disorders.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
15mo left

Started Jan 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Jan 2023Jul 2027

First Submitted

Initial submission to the registry

January 5, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

January 25, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

January 25, 2023

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 25, 2026

Expected
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 25, 2027

Last Updated

September 26, 2025

Status Verified

September 1, 2025

Enrollment Period

3.4 years

First QC Date

January 5, 2023

Last Update Submit

September 23, 2025

Conditions

Keywords

video polysomnographynew sleep detection device

Outcome Measures

Primary Outcomes (2)

  • Effective sleep duration (in minutes)

    evaluated by vPSG

    Month 6

  • Effective sleep duration (in minutes)

    evaluated by ESM device

    Month 6

Secondary Outcomes (20)

  • Time spent in bed (in minutes)

    Month 6

  • Time spent in bed (in minutes)

    Month 6

  • Sleep efficiency (Total sleep time/Time spent in bed)

    Month 6

  • Sleep efficiency (Total sleep time/Time spent in bed)

    Month 6

  • Sleep latency (in minutes)

    Month 6

  • +15 more secondary outcomes

Study Arms (2)

Patients with sleep disorders (TS+)

EXPERIMENTAL

video polysomnography; the new ESM "intelligent duvet" device

Device: night recording

control group without sleep disorder (TS-)

EXPERIMENTAL

video polysomnography; the new ESM "intelligent duvet" device

Device: night recording

Interventions

The patients/controls will arrive in the evening at the Sleep Laboratory (Functional Exploration Department of the Nervous System of the Clermont-Ferrand University Hospital) to carry out complete vPSG and test the new ESM "intelligent duvet"device. A qualified technician will place the electrodes according to the procedures usually followed at the Sleep Center for vPSG recording. The ESM duvet will be placed on the patient's body as a blanket, instead of the blankets normally provided by the hospital. Patients/controls will be monitored overnight by an infrared video camera.

Patients with sleep disorders (TS+)control group without sleep disorder (TS-)

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • For Sleep Disorder Group (TS+):
  • Men or women, aged 18 to 85
  • With a suspected sleep disorder (sleep apnea, restless legs syndrome RLS, syndrome of periodic leg movements during MPJS sleep, REM sleep behavior disorder, Parkinson's disease, Narcolepsy, etc.), requiring a confirmation of the diagnosis in vPSG.
  • Cooperation and understanding to strictly comply with the conditions set out in the protocol - Acceptance of the protocol and signing of a written consent
  • Affiliation to the social security system
  • For Control Group (TS- ):
  • Men or women, aged 18 to 85
  • Having no sleep disorder: the Pittsburgh PSQI sleep quality index (Buysse et al., 1989) must be \<5.
  • Cooperation and understanding to strictly comply with the conditions set out in the protocol - Acceptance of the protocol and signing of a written consent
  • Affiliation to the social security system

You may not qualify if:

  • For Group TS+ and TS-:
  • Patients under guardianship or curatorship or safeguard of justice
  • Pregnant or breastfeeding women (given the low risk incurred, the verification will be done on simple declaration of the patient)
  • Patients with active implants
  • refusing to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Clermont-Ferrand, UMR INSERM 1107

Clermont-Ferrand, France

Location

MeSH Terms

Conditions

Sleep Wake Disorders

Condition Hierarchy (Ancestors)

Nervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: the 2 groups (patients with Sleep Disorder Group (TS+) and the control group (TS-)) will receive the same intervention.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 5, 2023

First Posted

January 25, 2023

Study Start

January 25, 2023

Primary Completion (Estimated)

June 25, 2026

Study Completion (Estimated)

July 25, 2027

Last Updated

September 26, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations